Kala Pharmaceuticals Inc.

NASDAQ: KALA · Real-Time Price · USD
8.14
0.07 (0.87%)
At close: Aug 15, 2025, 10:08 AM

Kala Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.99 -0.4 -1.29 -0.55
PEG Ratio
0.02 0.01 0.02 -0.06
PS Ratio
n/a n/a 14.91 7.02
PB Ratio
3.11 2.27 3.06 4.70
P/FCF Ratio
-1.29 -0.6 -0.73 -0.72
P/OCF Ratio
-1.3 -0.61 -0.74 -0.73
OCF/S Ratio
n/a n/a -20.27 -9.63
Debt / Equity Ratio
2.62 4.84 2.26 4.77
Quick Ratio
3.11 6.33 3.05 3.09
Current Ratio
3.11 6.33 3.35 3.32
Asset Turnover
n/a n/a 0.04 0.08
Interest Coverage
-7.09 -6.73 -11.2 -13.06
Return on Equity
-3.12 -5.62 -2.36 -8.49
Return on Assets
-0.69 -0.75 -0.52 -1.02
Return on Invested Capital
-0.83 -0.81 -0.01 -1.13
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a 0.34 0.64
Net Profit Margin
n/a n/a -11.52 -12.69
Pretax Profit Margin
n/a n/a -11.52 -12.69
Operating Profit Margin
n/a n/a -20.9 -9.74
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -9.43 -11.74